Target Price | $30.50 |
Price | $4.58 |
Potential |
565.94%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Precision BioSciences, Inc. 2026 .
The average Precision BioSciences, Inc. target price is $30.50.
This is
565.94%
register free of charge
$60.00
1,210.04%
register free of charge
$13.00
183.84%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Precision BioSciences, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Precision BioSciences, Inc. stock has an average upside potential 2026 of
565.94%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 68.70 | 15.26 |
40.98% | 77.79% | |
EBITDA Margin | -34.12% | -335.58% |
58.13% | 883.55% | |
Net Margin | 10.44% | -405.20% |
108.29% | 3,982.46% |
4 Analysts have issued a sales forecast Precision BioSciences, Inc. 2025 . The average Precision BioSciences, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Precision BioSciences, Inc. 2025 . The average Precision BioSciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Precision BioSciences, Inc. Analysts have issued a net profit forecast 2025. The average Precision BioSciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.04 | -5.86 |
106.52% | 663.46% | |
P/E | negative | |
EV/Sales | negative |
2 Analysts have issued a Precision BioSciences, Inc. forecast for earnings per share. The average Precision BioSciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Precision BioSciences, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 21 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
BMO Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 22 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 21 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 19 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 19 2025 |
Locked
BMO Capital:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 10 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 22 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.